Distal esophageal carcinomas in Chinese patients vary widely in histopathology, but adenocarcinomas remain rare

Qin Huang(People's Hospital of Xinjiang Uygur Autonomous Region), Gregory Y. Lauwers(Moffitt Cancer Center), Hiroshi Mashimo(VA Boston Healthcare System), Hongyan Wu(Nanjing University of Chinese Medicine), Jiong Shi(St. Joseph's Hospital and Medical Center), Qi Sun(Fudan University), Qiang Zhou(Nanjing Drum Tower Hospital), Chenggong Yu(Nanjing Drum Tower Hospital), An‐Ning Feng(Nanjing Drum Tower Hospital), Xiangshan Fan(Anhui Medical University)
Human Pathology
June 1, 2012
10.1016/j.humpath.2012.02.018
Cited by 32

Related Papers

Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer
|Nature Medicine|2004|2k
Radiofrequency Ablation in Barrett's Esophagus with Dysplasia
|New England Journal of Medicine|2009|1.4k
MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Program
|Blood|2013|683
Efficacy, Safety, and Biomarkers of Neoadjuvant Bevacizumab, Radiation Therapy, and Fluorouracil in Rectal Cancer: A Multidisciplinary Phase II Study
|Journal of Clinical Oncology|2009|507
Founder and Recurrent CDH1 Mutations in Families With Hereditary Diffuse Gastric Cancer
|JAMA|2007|455